Document download

Please enter your email address to download the document - once you’ve submitted this you will be able to download any documents from the website in this session.

Not downloaded documents before? Please click here

Alternatively download the document here.

We will use the information you enter into this form to keep you up to date on our products and services which we think you may be interested in. You can unsubscribe from these emails at any time by clicking the unsubscribe link at the bottom of emails or by emailing [email protected]. To find out more about how we use your personal data, please see our Privacy Policy.

I don’t want to receive regular emails about your products and services

Downloaded documents before? Please click here

The Oliver Wight EAME website uses cookies by continuing to browse the website you are agreeing to our use of cookies. Further information

Healing Healthcare. Transforming the drug life cycle

Healing Healthcare. Transforming the drug life cycle

Healing Healthcare. Transforming the drug life cycle
(PDF Document (6.51MB))

Gary Connors, Oliver Wight Associate

Big pharmaceutical organisations will tell you that innovation is at the heart of what they do. Whether they aspire to helping people "Do More, Live Longer, Feel Better" or are striving to "Save and Improve Lives" they all rely on robust research and disciplined development processes to bring new drugs to market in a cost­effective way. On average, the industry introduces 30 new drugs per year at a total annual cost of nearly $100bn. The lead-time from discovery to launch of each of these drugs is usually over 10 years and the number of failed candidates for each successful launch is over 25,000, which poses the question, what should big pharmaceutical companies be doing differently in the 21st century to improve their rate of success?


Back to Books